摘要 |
<p>Compound of formula (I) and salts thereof are provided: Wherein R1, R2, R4 and R5 are as defined in the specification. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.</p> |
申请人 |
GLAXO GROUP LIMITED;BRADLEY, DANIEL, MARCUS;CHAN, WAI, NGOR;WARD, SIMON, E. |
发明人 |
BRADLEY, DANIEL, MARCUS;CHAN, WAI, NGOR;WARD, SIMON, E. |